Targeted News Service

GSK's Shingrix Prefilled Syringe Presentation Approved by the European Commission
January 07, 2026

LONDON, England, Jan. 7 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release:

* * *

GSK's Shingrix (Recombinant Zoster Vaccine) prefilled syringe presentation approved by the European Commission

* Prefilled syringe offers healthcare professionals a convenient administration option

* New presentation will begin rolling out across EU countries in 2026

* Shingles affects approximately . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form